Ahorsu Daniel Kwasi, Lin Chung-Ying, Imani Vida, Saffari Mohsen, Griffiths Mark D, Pakpour Amir H
Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong.
Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27.
The emergence of the COVID-19 and its consequences has led to fears, worries, and anxiety among individuals worldwide. The present study developed the Fear of COVID-19 Scale (FCV-19S) to complement the clinical efforts in preventing the spread and treating of COVID-19 cases.
The sample comprised 717 Iranian participants. The items of the FCV-19S were constructed based on extensive review of existing scales on fears, expert evaluations, and participant interviews. Several psychometric tests were conducted to ascertain its reliability and validity properties.
After panel review and corrected item-total correlation testing, seven items with acceptable corrected item-total correlation (0.47 to 0.56) were retained and further confirmed by significant and strong factor loadings (0.66 to 0.74). Also, other properties evaluated using both classical test theory and Rasch model were satisfactory on the seven-item scale. More specifically, reliability values such as internal consistency ( = .82) and test-retest reliability (ICC = .72) were acceptable. Concurrent validity was supported by the Hospital Anxiety and Depression Scale (with depression, = 0.425 and anxiety, = 0.511) and the Perceived Vulnerability to Disease Scale (with perceived infectability, = 0.483 and germ aversion, r = 0.459).
The Fear of COVID-19 Scale, a seven-item scale, has robust psychometric properties. It is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying COVID-19 fears among individuals.
新型冠状病毒肺炎（COVID-19）的出现及其后果引发了全球范围内个人的恐惧、担忧和焦虑。本研究开发了COVID-19恐惧量表（FCV-19S），以补充预防COVID-19传播和治疗的临床工作。
样本包括717名伊朗参与者。FCV-19S的项目是在广泛审查现有恐惧量表、专家评估和参与者访谈的基础上构建的。进行了多项心理测量测试，以确定其信度和效度特性。
经过专家组审查和校正的项目-总分相关测试，保留了7个校正项目-总分相关可接受（0.47至0.56）的项目，并通过显著且强的因子载荷（0.66至0.74）进一步确认。此外，使用经典测试理论和Rasch模型评估的其他特性在这个七项量表上也令人满意。更具体地说，诸如内部一致性（=0.82）和重测信度（ICC=0.72）等信度值是可接受的。医院焦虑抑郁量表（抑郁，=0.425；焦虑，=0.511）和疾病易感性感知量表（感知感染性，=0.483；细菌厌恶，r=0.459）支持了同时效度。
COVID-19恐惧量表是一个七项量表，具有强大的心理测量特性。它在评估普通人群对COVID-19的恐惧方面是可靠且有效的，也将有助于减轻个体对COVID-19的恐惧。
